Seizure protection by intrapulmonary delivery of propofol hemisuccinate

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 1, 2011, Pages 215-222

  Dhir, Ashish ^a   Zolkowska, Dorota ^a   Murphy, Randall B ^c   Rogawski, Michael A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Medkura Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; BICUCULLINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; PENTETRAZOLE; PICROTOXIN; PROPOFOL; PROPOFOL HEMISUCCINATE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG POTENCY; DRUG TOLERABILITY; GENERAL ANESTHESIA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; SEIZURE; SLEEP; TONIC SEIZURE;

ADMINISTRATION, INHALATION; ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; MALE; MICE; NEUROPROTECTIVE AGENTS; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 78650783575     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.173591     Document Type: Article

References (53)

1. Ahuja S and Germano IM (1998) Anticonvulsant and neuronal protective effects of propofol on experimental status epilepticus. J Epilepsy 11:168-176.
2. Akula KK, Dhir A, and Kulkarni SK (2008) Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. Eur J Pharmacol 587:129-134.
3. Aurora SK, Rozen TD, Kori SH, and Shrewsbury SB (2009) A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. Headache 49:826-837.
4. Arif H and Hirsch LJ (2008) Treatment of status epilepticus. Semin Neurol 28:342-354.
5. Baker MT and Naguib M (2005) Propofol: the challenges of formulation. Anesthesiology 103:860-876.
6. Borowicz KK and Czuczwar SJ (2003) Effects of etomidate, ketamine or propofol, and their combinations with conventional antiepileptic drugs on amygdala-kindled convulsions in rats. Neuropharmacology 45:315-324.
7. Chan MH, Lee CC, and Chen HH (2006) Effects of toluene on seizures induced by convulsants acting at distinct ligand-gated ion channels. Toxicol Lett 160:179-184.
8. Chessick RD (1953) Histochemical study of the distribution of esterases. J Histochem Cytochem 1:471-485.
9. Cockshott ID (1985) Propofol ('Diprivan') pharmacokinetics and metabolism - an overview. Postgrad Med J 61 (Suppl 3):45-50.
10. Cockshott ID, Douglas EJ, Plummer GF, and Simons PJ (1992) The pharmacokinetics of propofol in laboratory animals. Xenobiotica 22:369-375.
11. Coughenour LL, Mclean JR, and Parker RB (1977) A new device for the rapid measurement of impaired motor function in mice. Pharmacol Biochem Behav 6:351-353.
12. Crompton G (2006) A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J 15:326-331.
13. Dawidowicz AL, Fornal E, Mardarowicz M, and Fijalkowska A (2000) The role of human lungs in the biotransformation of propofol. Anesthesiology 93:992-997.
14. De Riu PL, Petruzzi V, Testa C, Mulas M, Melis F, Caria MA, and Mameli O (1992) Propofol anticonvulsant activity in experimental epileptic status. Br J Anaesth 69:177-181.
15. Dhir A, Naidu PS, and Kulkarni SK (2006) Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry 30:1478-1485.
16. Finn DA and Crabbe JC (1999) Chronic ethanol differentially alters susceptibility to chemically induced convulsions in withdrawal seizure-prone and -resistant mice. J Pharmacol Exp Ther 288:782-790.
17. Flaishon R, Windsor A, Sigl J, and Sebel PS (1997) Recovery of consciousness after thiopental or propofol. Bispectral index and isolated forearm technique. Anesthesiology 86:613-619.
18. Hales TG and Lambert JJ (1991) The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br J Pharmacol 104:619-628.
19. A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 79:781-788.
20. A. response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 81: 988-994.
21. Hasan Z, Hasan M, al-Hader A, and Takrouri M (1991) A comparison of the anticonvulsant effects of propofol and thiopentone against pentylenetetrazol- induced convulsions in the rat. Clin Exp Pharmacol Physiol 18:691-695.
22. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
23. Kaminski RM, Shippenberg TS, Witkin JM, and Rocha BA (2005) Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures. Neurosci Lett 382:51-55.
24. Kokate TG, Cohen AL, Karp E, and Rogawski MA (1996) Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35:1049-1056.
25. Lee SR and Cheun JK (1999) Propofol administration reduces hippocampal neuronal damage induced by kainic acid in rats. Neurol Res 21:225-228.
26. A receptors. Br J Anaesth 90:199-211.
27. Lowson S, Gent JP, and Goodchild CS (1990) Anticonvulsant properties of propofol and thiopentone: comparison using two tests in laboratory mice. Br J Anaesth 64:59-63.
28. Matot I, Neely CF, Katz RY, and Neufeld GR (1993) Pulmonary uptake of propofol in cats. Effect of fentanyl and halothane. Anesthesiology 78:1157-1165.
29. Micklethwaite AV and Pleuvry BJ (1993) Comparison of anticonvulsant effects of intravenous propofol, thiopentone and methohexitone in bicuculline-induced convulsions in mice. Br J Pharmacol 108:P291-P291.
30. Ohmori H, Sato Y, and Namiki A (2004) The anticonvulsant action of propofol on epileptiform activity in rat hippocampal slices. Anesth Analg 99:1095-1101.
31. Oka Y, Mitsui M, Kitahashi T, Sakamoto A, Kusuoka O, Tsunoda T, Mori T, and Tsutsumi M (2006) A reliable method for intratracheal instillation of materials to the entire lung in rats. J Toxicol Pathol 19:107-109.
32. Ozbakis-Dengiz G and Bakirci A (2009) Anticonvulsant and hypnotic effects of amiodarone. J Zhejiang Univ Sci B 10:317-322.
33. Ouyang W, Wang G, and Hemmings HC Jr (2003) Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. Mol Pharmacol 64:373-381.
34. Patton JS (1996) Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3-36.
35. Patton JS and Byron PR (2007) Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67-74.
36. Peduto VA, Concas A, Santoro G, Biggio G, and Gessa GL (1991) Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology 75:1000-1009.
37. Prasad A, Worrall BB, Bertram EH, and Bleck TP (2001) Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 42:380-386.
38. Rasmussen PA, Yang Y, and Rutecki PA (1996) Propofol inhibits epileptiform activity in rat hippocampal slices. Epilepsy Res 25:169-175.
39. Rastogi SK and Ticku MK (1986) Anticonvulsant profile of drugs which facilitate ABAergic transmission on convulsions mediated by a GABAergic mechanism. Neuropharmacology 25:175-185.
40. Rehberg B and Duch DS (1999) Suppression of central nervous system sodium channels by propofol. Anesthesiology 91:512-520.
41. Reves JG, Glass PSA, Lubarsky DA, McEvoy RD, and Martinez-Ruiz R (2009) Intravenous anesthetics, in Miller's Anesthesia, 7th ed (Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, and Young WL eds) pp 719-768, Churchill Livingstone/Elsevier, Philadelphia.
42. Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D, Schubert D, and Chang J (1999) Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 73:2524-2530.
43. Saint-Maurice C, Cockshott ID, Douglas EJ, Richard MO, and Harmey JL (1989) Pharmacokinetics of propofol in young children after a single dose. Br J Anaesth 63:667-670.
44. Schanker LS (1978) Drug absorption from the lung. Biochem Pharmacol 27:381-385.
45. Schanker LS, Mitchell EW, and Brown RA Jr (1986) Pulmonary absorption of drugs in the dog: comparison with other species. Pharmacology 32:176-180.
46. Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, and Youngs EJ (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90:1502-1516.
47. Shyr MH, Yang CH, Kuo TB, Pan WH, Tan PP, and Chan SH (1993) Power spectral analysis of the electroencephalographic and hemodynamic correlates of propofol anesthesia in the rat: intravenous bolus administration. Neurosci Lett 153:161-164.
48. 14C-propofol after intravenous dosing to rat, dog and rabbit. Xenobiotica 21:1243-1256.
49. Vanbever R (2005) Performance-driven, pulmonary delivery of systemically acting drugs. Drug Discov Today Technol 2:30-46.
50. Vansant G, Trauger RJ, Cameron A, Vendemelio M, Kreitschitz S, Carlo AT, Banaszczyk MG, Carlo DJ, Hendler S, and Ill CR (2007) Propofol hemisuccinate suppression of experimental autoimmune encephalomyelitis. Autoimmunity 40: 180-186.
51. Vatter AE, Reiss OK, and Newman JK (1971) The subcellular distribution of some hydrolytic enzymes in lung. Chest 59 (Suppl):11S-12S.
52. Yamaguchi S and Rogawski MA (1992) Effects of anticonvulsant drugs on 4-aminopyridine- induced seizures in mice. Epilepsy Res 11:9-16.
53. Zhan RZ, Qi S, Wu C, Fujihara H, Taga K, and Shimoji K (2001) Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygenglucose deprivation in rat hippocampal slices in correlation with N-methyl-Daspartate receptor inhibition. Crit Care Med 29:808-813.